A NOVEL COLORECTAL CANCER SUSCEPTIBILITY SNP IN THE EIF3H PROMOTER INFLUENCES PATIENT SURVIVAL AND RESPONSE TO TREATMENT

Documenti analoghi

• A novel colorectal cancer susceptibility SNP in the EIF3F1 promoter influences patient survival and response to treatment
  di: Smith, C, et al.
  Pubblicazione: (2010)
• BRAF and NRAS locus-specific variants have different outcomes on survival to colorectal cancer
  di: Summers, MG, et al.
  Pubblicazione: (2016)
• THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
  di: Maughan, T, et al.
  Pubblicazione: (2010)
• HIGH THROUGHPUT SOMATIC PROFILING OF THE RAS-RAF-MAP AND PI3K-PTEN-AKT PATHWAYS IN ADVANCED COLORECTAL CANCER AND CORRELATIONS WITH RESPONSE TO CETUXIMAB
  di: Smith, C, et al.
  Pubblicazione: (2010)
• THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
  di: Maughan, T, et al.
  Pubblicazione: (2010)